Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
1.180
-0.040 (-3.28%)
At close: Mar 6, 2026, 4:00 PM EST
1.200
+0.020 (1.69%)
After-hours: Mar 6, 2026, 6:11 PM EST
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Definitive Healthcare stock have an average target of 3.43, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 190.68% from the current stock price of 1.18.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +154.24% | Feb 27, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +69.49% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $2.75 | Sell | Maintains | $3 → $2.75 | +133.05% | Dec 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +238.98% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +408.47% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
232.26M
from 241.52M
Decreased by -3.83%
Revenue Next Year
233.22M
from 232.26M
Increased by 0.41%
EPS This Year
0.21
from -1.30
EPS Next Year
0.23
from 0.21
Increased by 9.88%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 245.1M | 247.1M | |
| Avg | 232.3M | 233.2M | |
| Low | 216.6M | 216.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5% | 6.4% | |
| Avg | -3.8% | 0.4% | |
| Low | -10.3% | -6.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.28 | 0.30 | |
| Avg | 0.21 | 0.23 | |
| Low | 0.16 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 45.2% | |
| Avg | - | 9.9% | |
| Low | - | -29.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.